CAVA vs RGEN Comparison

Cava is an emerging fast-casual restaurant chain with $1.2 billion in sales across 439 US company-owned units in 2025. The firm derives most of its revenue from the sale of Mediterranean- and Greek-inspired customizable bowls, salads, pita wraps, and beverages, using an assembly-line format. Cava centrally prepares and manufactures the sauces and dips served in its restaurants and sold in grocery stores. All of Cava's revenue is in the US, with the majority of its footprint in the Southeast and Southwest.

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, and other life science companies. It sells four main product categories: filtration and fluid management is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia-Pacific contribute about 44%, 37%, and 19% of revenue, respectively.